Genes for ischaemic stroke: Strategies for their detection

Journal of Hypertension

Volumn 14, Issue 3, 1996, Pages 277-285

  Sharma, Pankaj ^a,b  

^a GONVILLE AND CAIUS COLLEGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Candidate genes; Cerebral infarction; Genetics; Linkage; Strategy for investigation; Stroke

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; DIPEPTIDYL CARBOXYPEPTIDASE; FREE RADICAL; HOMOCYSTEINE; PROTEIN C; SOMATOMEDIN C;

BLOOD CLOTTING; BRAIN INFARCTION; FAMILY HISTORY; GENE LOCUS; GENETIC LINKAGE; HOMOCYSTINURIA; HUMAN; HYPERTENSION; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT SURVEY; STROKE; TWINS;

EID: 0029919236     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199603000-00002     Document Type: Short Survey

References (62)

1. Sandercock P: Collaborative world-wide overviews of randomised trials. Ann N Y Acad Sci 1973, 703:149-154.
2. Barker DJ: Fetal origins of coronary heart disease. BMJ 1995, 311:171-174.
3. Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR: Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989, 25:382-390.
4. Schomere DF, Marks MP, Steinberg GK, Johnstone IM, Boothroyd DB, Ross MR, et al.: The anatomy of the posterior communicating artery as a risk factor for ischemic cerebral infarction. N Engl J Med 1994, 330:1565-1570.
5. Morgagni G: De sedibus, et causis morborum per anatomen indagatis. Venice; 1961.
6. Kiely DK, Wolf PA, Cupples LA, Baiser AS, Myers RH: Familial aggregation of stroke. The Framingham Study. Stroke 1993, 24:1366-1371.
7. Graffagnino C, Gasecki AP, Doig GA, Hachinski VC: The importance of family history in cerebrovascular disease. Stroke 1994, 25:1599-1604.
8. Khaw KT, Barrett-Connor E: Family history of stroke as an independent predictor of ischemic heart disease in men and stroke in women. Am J Epidemiol 1986, 123:59-66.
9. Welin L, Svardsudd K, Wilhelmsen L, Larsson B, Tibblin G: Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med 1987, 317:521-526.
10. Brass LM, Shaker LA: Family history in patients with transient ischemic attacks. Stroke 1991, 22:837-841.
11. Brass LM, Isaacsohn JL, Merikangas KR, Robinette CD: A study of twins and stroke. Stroke 1992, 23:221-223.
12. Coyle P, Odenheimeer DJ, Sing CF: Cerebral infarction after middle cerebral artery occlusion in progenies of spontaneously stroke-prone and normal rats. Stroke 1984, 15:711-716.
13. Brattstrom L, Lindgren A: Hyperhomocysteinemia as a risk factor for stroke. Neurol Res 1982, 14 (suppl 2):81-84.
14. Brattstrom L, Hardebo JE, Hultberg BL. Moderate homocysteinemia - a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 1984, 15:1012-1016.
15. Boers GHJ, Smals AGH, Trijbels FJM, Fowler B, Bakkeren JAJM, Schoonderwaldt HC, et al.: Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985, 313:709-715.
16. Mereau-Richard C, Muller JP, Faivre E, Ardouin P, Rousseaux J: Total plasma homocysteine determination in subjects with premature cerebral vascular disease. Clin Chem 1991, 37:126.
17. Brattstrom L, Israelsson B, Norrving B, et al.: Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease - effects of pyridoxine and folic acid treatment. Atherosclerosis 1990, 81:51-60.
18. Mudd SH, Skovky F, Levy HL, et al.: The natural history of homocystinuria due to cystathionine b-synthase deficiency. Am J Hum Genet 1985, 37:1-31.
19. Erbe RW: Inborn errors of folate metabolism. In Folates and Pterins. Edited by Blakely RI. New York: John Wiley; 1986:413-465.
20. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al.: Hyperhomocyst(e)inemia: an independent risk factor for vascular disease. N Engl J Med 1991, 324:1149-1155.
21. McGill JJ, Mettler G, Rosenblatt DS, Scriver CR: Detection of heterozygotes for recessive alleles. Homocyst(e)inemia: a paradigm of pitfalls in phenotypes. Am J Med Genet 1990, 36:45-52.
22. Kraus JP, Le K, Swaroop M, Ohura T, Tahara T, Rosenberg LE, et al.: Human cystathionine b-synthase cDNA: sequence, alternative splicing and expression in cultured cells. Hum Mol Genet 1993, 2:1633-1638.
23. Tournier-Lasserve E, Joutel A, Melki J, Wiessenbach J, Lathrop GM, Mas JL, et al.: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. nature Genet 1993, 3:256-259.
24. Joutel A, Bousser MG, Biousse V, Labauge P, Chabriaat H, Nibbio A, et al.: A gene for familial hemiplegic migraine maps to chromosome 19. Nature Genet 1993, 5:40-45.
25. Harrap SB: Genetics approaches to hypertension. In Textbook of Hypertension. Edited by Swales JD. Oxford: Blackwells Scientific; 1994:504-518.
26. Brown MJ: A theoretical analysis of the heterogeneity of hypertension [abstract]. Melbourne: International Society of Hypertension; 1994.
27. Levine GN, Keaney JF, Vita FA: Cholesterol reduction in cardiovascular disease. N Engl J Med 1995, 332:512-521.
28. Kasturi R, Yatsu FM, Alam R, Rogers S: Restriction fragment length polymorphism of the apoprotein A-I-C-III gene cluster in control and stroke-prone white and black subjects: racial differences. Stroke 1992, 23:1257-1264.
29. Reymer PWA, Gagne E, Groenemeyer BE, Zhang H, Forsyth I, Jansen H, et al.: A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nature Genet 1995, 10:28-34.
30. Scarabin PY, Bara L, Ricard S, Poirier O, Cambou JP, Arveiler D, et al.: Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study. Arteroscler Thromb 1993, 13:886-891.
31. Kannell MB, Wolf PA, Castelli WP, D'Agostino RB: Fibrinogen and risk of cardiovascular disease. JAMA 1987, 258:1183-1186.
32. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984, 311:501-505.
33. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH: Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993, 341:1165-1168.
34. Ridker PM, Hennekens CH, Stampfer MJ, Manson JE, Vaughan DE: Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994, 343:940-943.
35. Salomaa VV, Wu KK, Stinson VL, Kark JD, Folsom AR, Liao D, et al.: The association of fibrinolytic activity with asymptomatic carotid atherosclerosis: the ARIC study. Circulation 1993, 87:22.
36. Dahlback B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993, 90:1004-1008.
37. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al.: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994, 369:64-67.
38. van Bockxmeer FM, Baker RL, Taylor RR: Premature ischaemic heart disease and the gene for coagulation factor V. Nature Med 1995, 1:185.
39. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR: Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995, 332:912-917.
40. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al.: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 359:641-644.
41. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, Buring J, et al.: A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995, 332:705-711.
42. Sharma P, Carter ND, Barley J, Brown MM: Molecular approach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin I-converting enzyme. J Hum Hypertens 1994, 8:645-648.
43. Koller H, Stoll G, Sitzer M, Burk M, Schottler B, Freund HJK: Deficiency of both protein c and protein s in a family with ischemic strokes in young adults. Neurology 1994, 44:1238-1240.
44. Arima T, Motomura M, Nishiura Y, Tsujihata M, Okajima K, Abe H, et al.: Cerebral infarction in a heterozygote with variant antithrombin III. Stroke 1992, 23:1822-1825.
45. Ford PM, Brunet D, Lillicrap DP, Ford SE: Premature stroke in a family with lupus anticoagulant and antiphospholipid antibodies. Stroke 1990, 21:66-71.
46. Fath KA, Alexander RW, Delafontaine P: Abdominal coarctation increases insulin-like growth factor I mRNA levels in rat aorta. Circ Res 1993, 72:271-277.
47. Dempsey EC, Stenmark KR, McMurtry IF, O'Brien RF, Voelkel NF, Badesch DB: Insulin-like growth factor I and protein kinase C activation stimulate pulmonary artery smooth muscle cell proliferation through separate but synergistic pathways. J Cell Physiol 1990, 144:159-165.
48. Halliwell B: Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994, 344:721-724.
49. Witztum JL: The oxidation hypothesis of atherosclerosis. Lancet 1994, 344:793-795.
50. Allen CM: Clinical diagnosis of the acute stroke syndrome. Q J Med 1983, 52:515-523.
51. Deng HX, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hunt WY, et al.: Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 1993, 261:1047-1051.
52. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, et al.: A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994, 371:130-136.
53. Ott J: Cutting a Gordian knot in the linkage analysis of complex human traits. Am J Hum Genet 1990, 46:219-221.
54. Casari G, Barlassina C, Cusi D, Zagato L, Muirhead R, Righetti M, et al.: Association of the alpha-adducin locus with essential hypertension. Hypertension 1995, 25:320-326.
55. Lander ES, Schork NJ: Genetic dissection of complex traits. Science 1994, 265:2037-2048.
56. Lindpaintner K: Genetic linkage analysis in hypertension: principles and practice. J Hypertens 1992, 10:121-124.
57. Alberts MJ: Genetics of cerebrovascular disease. Stroke 1990, 21:III127-III130.
58. Kidd KK: Searching for major genes for psychiatric disorders. In Molecular Approaches to Human Polygene Disease. Chichester: Wiley; 1987:184-196.
59. Cudworth AG, Woodrow JC: Evidence for HLA-linked genes in 'juvenile' diabetes mellitus. BMJ 1975, 3:133-135.
60. Hashimoto L, Habita C, Beressi JP, Delepine M, Besse C, Deschamps I, et al.: Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 1994, 371:161-164.
61. Oliveno A, Cabib S, Puglisi-Allegra S: Nonhuman behavioral models in the genetics of disturbed behavior. J Psychiatr Res 1992, 26:367-382.
62. Lander ES, Botstein D: Mapping Mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 1989, 121:185-199.